NCT06581042View on ClinicalTrials.gov

Study to Assess Treatment Patterns and Outcomes With Upadacitinib in Adult Participants With Inflammatory Bowel Disease in Belgium

RecruitingOBSERVATIONAL
Enrollment

280

Participants

Timeline

Start Date

September 27, 2024

Primary Completion Date

September 30, 2029

Study Completion Date

September 30, 2029

Conditions
Ulcerative ColitisCrohn's Disease
Trial Locations (7)

1070

RECRUITING

Universite Libre de Bruxelles - Hopital Erasme /ID# 268632, Anderlecht

2820

RECRUITING

Imelda Ziekenhuis /ID# 268631, Bonheiden

4000

RECRUITING

CHU de Liège /ID# 267209, Liège

RECRUITING

Groupe Sante CHC - Clinique du MontLegia /ID# 268662, Liège

8500

RECRUITING

AZ Groeninge /ID# 268638, Kortrijk

9000

RECRUITING

UZ Gent /ID# 268630, Ghent

9100

RECRUITING

Vitaz /Id# 268637, Sint-Niklaas

Sponsors

Lead Sponsor

AbbVie
All Listed Sponsors
lead

AbbVie

INDUSTRY